BRIEF DEFINITIVE REPORT
T regulatory cells (T reg cells) function to temper the massive proinfl ammatory stimulus created by commensal bacteria within the gut. Evidence of their functional importance in suppressing gut infl ammation is observed by the fact that their absence permits the onset of gut autoimmunity ( 1, 2 ) . Therefore, manipulation of T reg cell function within the gut provides an attractive therapeutic approach in enforcing gut tolerance during times when the balance is shifted toward autoimmunity.
The ability of activated T cells to exit the blood and enter diff erent tissues of the body is " imprinted " on them within the secondary lymphoid organs by DCs ( 3, 4 ) . T cells homing to the small intestine lamina propria express the integrin ␣ 4 ␤ 7, which binds mucosal addressin cell adhesion molecule -1 and CC chemokine receptor (CCR) 9, whose ligand is secreted within the lamina propria ( 5 -8 ) . A population of CD103 ϩ DCs that primarily resides within the lamina propria, Peyer ' s patches, and mesenteric lymph nodes are responsible for imprinting a gut-homing capacity on T cells by an all-trans retinoic acid (RA) -dependent mechanism ( 1, 9 -11 ) .
It has been shown that CD4 ϩ FoxP3 − naive T cells can be converted into CD4 ϩ FoxP3 ϩ T reg cells (i.e., adaptive T reg cells [A-Tregs]) exhibiting the same suppressive and phenotypic characteristics as thymically derived, natural T reg cells (nTregs) both in vivo and in vitro ( 12 -16 ) . This conversion is dependent on TGF-␤ 1 and requires IL-2 in vitro ( 13, 17, 18 ) . The use of A-Tregs as a means of inducing tolerance has been demonstrated in numerous settings, including infl ammatory bowel disease and allotransplantation models ( 12, 15, 16, 19 ) . Improving the potency of A-Treg treatments is of great clinical interest, and harnessing imprinting mechanisms to target A-Tregs to a specifi c organ is one means to this end.
In this report, we use RA to generate a uni que population of A-Tregs in vitro that is able to home in vivo to the small intestine lamina propria.
We demonstrate that all-trans retinoic acid (RA) induces FoxP3 ؉ adaptive T regulatory cells (A-Tregs) to acquire a gut-homing phenotype ( ␣ 4 ␤ 7 ؉ CC chemokine receptor 9 ؉ ) and the capacity to home to the lamina propria of the small intestine. Under conditions that favor the differentiation of A-Tregs (transforming growth factor -␤ 1 and interleukin 2) in vitro, the inclusion of RA induces nearly all activated CD4 ؉ T cells to express FoxP3 and greatly increases the accumulation of these cells. In the absence of RA, A-Treg differentiation is abruptly impaired by profi cient antigen presenting cells or through direct co-stimulation. In the presence of RA, A-Treg generation occurs even in the presence of high levels of co-stimulation, with RA attenuating co-stimulation from interfering from FoxP3 induction. The recognition that RA induces gut imprinting, together with our fi nding that it enhances A-Treg conversion, differentiation, and expansion, indicates that RA production in vivo may drive both the imprinting and A-Treg development in the face of overt infl ammation.
RESULTS AND DISCUSSION
RA synergizes with TGF-␤ 1 to generate A-Tregs that home to the small intestine in vivo and express suppressive activity RA induces ␣ 4 ␤ 7 and CCR9 expression on CD4 ϩ T cells during in vitro activation ( 11 ) . As A-Tregs can be generated from naive CD4 ϩ FoxP3 Ϫ cells in vitro during stimulation in the presence of TGF-␤ 1 and IL-2, we addressed whether CD4 ϩ FoxP3 Ϫ T cells cultured with TGF-␤ 1, RA, Surprisingly, RA potently synergized with TGF-␤ 1 in driving FoxP3 induction. In addition to increasing the frequency and durability of these A-Tregs, RA also allowed FoxP3 expression to occur in the presence of high levels of co-stimulation, levels that normally prevent FoxP3 induction. These experiments highlight the central importance of RA in serving two roles: driving gut homing and permitting the development of A-Tregs in the presence of overt infl ammation. These data im plicate RA as a mediator of gut tolerance in vivo. IL-2 concentrations were kept constant, Ϯ RA, with TGF-␤ 1 (20 ng/ml, 10 ng/ml, 5 ng/ml, 1 ng/ml, and 0) titrated. (E) TGF-␤ -mediated Foxp3/GFP expression as a result of titrating concentrations of RA. Keeping IL-2 and TGF-␤ 1 constant, RA was titrated in serial dilutions (100 nM, 10 nM, 1 nM, 100 pM, 10 pM, 1 pM, and 0). All experiments shown are representative of at least n = 3 independent experiments.
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Ly5.2 ϩ FoxP3/GFP reporter mouse. Sorted CD4 ϩ CD25 Ϫ cells from a Ly5.2 ϩ mouse that did not contain the FoxP3/ GFP knock-in allele were used to generate a population of A-Tregs. As the A-Tregs were generated from mice lacking the FoxP3/GFP allele, it was impossible to sort them to purity after inducing FoxP3 expression in vitro, and thus, the A-Treg population used contained a substantial percentage of FoxP3 Ϫ cells (unpublished data). However, this does not diminish the utility of these cells in an in vivo competitive homing experiment. RA -T reg cells and A-Tregs were equally mixed and injected intravenously into recipient Ly5.1 ϩ mice, and various organs were analyzed for donor cells after 18 h ( Fig. 2 C ) . After at least 18 h, we did not observe reversion of CD4 ϩ FoxP3 ϩ RA -T reg cells to a CD4 ϩ FoxP3 Ϫ phenotype in vivo (see Fig. 5 A ) . As expected from their phenotype, the RA -T reg cells had the capacity to home to the small intestine lamina propria and were in the minority compared with A-Tregs in the blood and lung ( Fig. 2 D ) . There was also an accumulation of RA -T reg cells in the mesenteric lymph nodes and the Peyer ' s patches. Collectively, these data show that functionally suppressive T reg cells with a guthoming phenotype can be generated from CD4 ϩ FoxP3 Ϫ T cells in vitro, and this cell population has the capacity to home to the small intestine in vivo.
Co-stimulation and A-T reg cell generation: RA allows DCs to drive TGF-␤ 1 -mediated FoxP3 induction
To investigate the capacity of diff erent APC subsets to induce A-Treg generation in vitro, peptide-pulsed splenic CD19 ϩ B cells and CD11c ϩ DCs were analyzed for their ability to drive TGF-␤ 1 -dependent FoxP3 induction in CD4 ϩ OTII ϩ FoxP3 Ϫ cells harvested and purifi ed by sorting from the OTII ϩ FoxP3/ GFP mouse. A diff erence was observed between these two APC subsets to mediate conversion: B cells repeatedly induced conversion at rates between 40 -60%, with DCs inducing conversion at substantially lower rates of 0 -14% ( Fig. 3 A ; and Fig. S1 , available at http://www.jem.org/cgi/content/ full/jem.20070719/DC1), consistent with a previous study ( 25 ) . The ability of B cells and DCs to mediate conversion was further analyzed by titrating exogenous TGF-␤ 1, further substantiating the diff erential capacity of these APC subsets to mediate T reg cell generation (Fig. S1) .
When the total number of CD4 ϩ T cells per well after culture was quantifi ed, DCs generated far more CD4 ϩ T cells per well then B cells ( Fig. 3 B ) . This was expected, given the diff ering capacities of these APC subsets to activate T cells through their diff erential co-stimulatory molecule expression, with DCs far superior at activating CD4 ϩ T cells than resting B cells ( 26 ) . We hypothesized that the capacity of APCs to activate T cells through co-stimulatory molecule expression, such as CD80/86, is inversely correlated with their ability to support the generation of A-Tregs. By extension of this hypothesis, the greater the absolute yield of daughter T cells generated by an APC, the fewer the number of FoxP3-expressing T cells. To test this hypothesis directly, we examined the ability of CD80/86 knockout splenic DCs and B cells and IL-2 under activating conditions would generate cells with a CD4 ϩ FoxP3 ϩ ␣ 4 ␤ 7 ϩ CCR9 ϩ phenotype. We sorted CD4 ϩ FoxP3 Ϫ cells from the FoxP3/GFP reporter mouse to > 99.9% purity, using this approach throughout the study ( 20 ) . After 5 d of activation by plate-bound ␣ CD3/ ␣ CD28 with TGF-␤ 1, IL-2, and RA, we observed the emergence of CD4 ϩ FoxP3 ϩ ␣ 4 ␤ 7 ϩ CCR9 ϩ T cells (RA -T reg cells; Fig.  1 A ) . Concordant with conversion was the induction of CD25, a marker for both T reg cells and activated T cells, and the expression of CD103, which is induced by TGF-␤ 1 and identifi es an in vivo subset of eff ector/memory T reg cells, which are more potent suppressors than T reg cells lacking expression of this molecule ( 21 -23 ) . These data show that a population bearing the phenotype of a gut-homing T reg cell population was generated. Additionally, we observed a > 90% conversion rate of CD4 ϩ FoxP3 Ϫ to CD4 ϩ FoxP3 ϩ T cells in the presence of RA, compared with considerably less in its absence ( Fig. 1 B ) . Between experiments, we observed variable conversion rates ranging between 15 -50% in the culture conditions of IL-2 and TGF-␤ 1, with the addition of RA consistently increasing FoxP3 expression to 90% or greater. This synergy between TGF-␤ 1 and RA in inducing FoxP3 expression could be blocked by the addition of the selective RA receptor antagonist LE540 ( Fig. 1 C ) . RA was able to enhance conversion throughout a titration of TGF-␤ 1, although RA, by itself, did not induce conversion. The inability of RA to induce FoxP3 expression without the addition of exogenous TGF-␤ 1 indicates that conversion was exclusively dependent on exogenous TGF-␤ 1 ( Fig. 1 D ) . Any endogenous TGF-␤ 1 potentially present within our culture medium was unable to mediate this eff ect. When RA was titrated against constant TGF-␤ 1 and IL-2, RA was able to enhance TGF-␤ 1 -dependent conversion even at subnanomolar concentrations ( Fig. 1 E ) . For future experiments within this study, unless otherwise indicated, we used 1 nM RA in our cultures. This was done for two reasons: fi rst, at concentrations < 1 nM, the percentage of T cells expressing FoxP3 begins to decrease, and second, it has been observed that RA has antiproliferative eff ects on T cells at high concentrations (30 -100 nM RA suppresses T cell proliferation, whereas doses < 5 nM do not; unpublished data) ( 24 ) . Results similar to those shown in Fig. 1 (A -D) were observed using 1 nM RA. These data show that RA potently enhances TGF-␤ 1 -dependent FoxP3 induction.
The suppressive activity of RA -T reg cells was measured relative to that of A-Tregs and freshly harvested nTregs in an in vitro suppressor assay. The data show that RA -T reg cells are potent suppressors of T eff ector cells in vitro ( Fig. 2,  A and B ) . It is interesting to speculate that the RA -T reg cells may even be more potent suppressors of T eff ector cell proliferation, as indicated by their ability to suppress at T reg cell/T eff ector cell ratios that nTregs and A-Tregs could not suppress.
To examine the in vivo homing capacity of RA -T reg cells, we performed an in vivo competitive homing experiment ( 3, 4 ). RA -T reg cells were generated in vitro from a to mediate both conversion and T cell expansion. The CD80/86 knockout DCs were able to induce TGF-␤ 1 -dependent FoxP3 expression in CD4 ϩ T cells at a substantially increased rate in comparison with WT DCs (81.33% [SD = 2.31] compared with 7.9% [SD = 1.14]; Fig. 3 A ) . There was no 
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We next addressed whether B cell activation and the acquisition of heightened co-stimulatory molecule expression impaired the ability to induce conversion. When B cells were preactivated for 48 h by either LPS or agonistic-␣ CD40 supplemented with IL-4 and then used as APCs, B cell -mediated conversion was impaired ( Fig. 3 C ) .
When CD4 ϩ T cells were activated using WT or CD80/86 knockout DCs in the presence of exogenous IL-2, considerably more T cells per well were generated by WT DCs in comparison with CD80/86 knockout DCs (19. or both did not aff ect this observed diff erence ( Fig. 3 B ) . Upon the addition of TGF-␤ 1 to these cultures, the decrease of T cell numbers between WT and CD80/86 knockout DCs inversely correlated with a substantial increase in the number of FoxP3-expressing T cells in the CD80/86 knockout group versus the WT group ( Fig. 3 B ) .
The addition of ␣ CD154 did not lead to a considerable change in T cell numbers generated by DCs with the addition of exogenous IL-2 (19.64 ϫ 10 4 [SD = 2.42 ϫ 10 4 ] compared with 11.13 ϫ 10 4 [SD = 7.75 ϫ 10 4 ] with ␣ CD154; Fig. 3 B ) . No diff erence in T cell number was again observed with the further addition of RA or TGF-␤ 1, or both. Additionally, there was no considerable increase in the numbers of Fig. 3 B ) . Despite the enhanced conversion imparted by ␣ CD154 in our DC/T cell co-cultures in Fig. 3 A , this result was not entirely unexpected. First, even with a CD154/ CD40 blockade, DCs will still express levels of CD80/86 that are suffi cient in expanding T cells. Second, the increase in DCmediated conversion caused by ␣ CD154 may not be enough to net an absolute increase in T reg cell numbers in this experimental system. B cells, CD80/86 knockout B cells, and B cells cultured with ␣ CD154 all generated similar total numbers of T cells in all culture conditions. This was expected and is likely caused by the low levels of co-stimulatory molecule expression on the surface of resting B cells ( 26 ) . Collectively, these data support our hypothesis that under conditions favoring conversion, the greater the absolute yield of T cells generated by an APC and the fewer the number of T cells expressing FoxP3. Further substantiating this is our fi nding that increasing levels of plate-bound co-stimulation inversely correlates with the absolute number of A-Tregs generated (Fig. S2 , available at http://www.jem.org/cgi/content/full/jem.20070719/DC1).
To directly implicate CD28 as a major mediator aff ecting FoxP3 induction, we varied the magnitude of ␣ CD28 costimulation in an in vitro assay in which plate-bound agonistic ␣ CD28 was titrated against saturating concentrations of platebound ␣ CD3. It was observed that ␣ CD28 concentration had an inverse relationship with A-Treg generation, with optimal conversion occurring at ␣ CD28 concentrations of 1 g/ml and below. At saturating concentrations (10 g/ml ␣ CD28), no conversion was observed ( Fig. 3 D ) . Collectively, these data show that high levels of CD80/86 co-stimulation, such as those observed on splenic CD11c ϩ DCs, impairs TGF-␤ 1 -driven FoxP3 induction and A-Treg generation while inducing the presence of RA ( Fig. 4 C ) . Importantly, RA enhances TGF-␤ 1 -mediated FoxP3 expression in the absence of any ␣ CD28 signal and just the presence of ␣ CD3 ( Fig. 4 C  and Fig. 3 D ) . Collectively, these data show that RA enhances FoxP3 induction and attenuates co-stimulation from interfering with T reg cell generation through a mechanism independent of dampening T cell activation and proliferation. Fur thermore, co-stimulation is not needed for RA to enhance FoxP3 induction.
RA -T reg cells are refractory to reversion in vivo
RA is known to induce diff erentiation in a variety of primary and tumor cell types. As such, we addressed whether RA -T maximal expansion of T cells. In the context of minimal to no CD80/86 co-stimulation, such as levels present on resting B cells and CD80/86 knockout DCs, little to no expansion occurs, with TGF-␤ 1 -dependent FoxP3 expression and T reg cell generation the result.
The addition of RA to our assays greatly enhanced both the percentage and total numbers of T cells expressing FoxP3 in a TGF-␤ 1 -dependent manner ( Fig. 3, A and B ; Fig. S1 ; and Fig. S2) . Notably, the addition of RA to our DC/T cell co-cultures increased the percentage of T cells expressing FoxP3 from 7.94% (SD = 1.14) to 72% (SD = 2; Fig. 3 A ) . Additionally, the combination of RA with TGF-␤ 1 resulted in a net increase in the numbers of Fig. 3 B and Fig. S1 ). Furthermore, RA reversed co-stimulation from suppressing, in dose-dependent manner, the net yield of FoxP3 ϩ T cells, as concentrations of plate-bound ␣ CD28 now positively correlate with FoxP3 ϩ T cell numbers (Fig. S2) . Across all concentrations of platebound ␣ CD28, as well as in the presence of only a TCR signal with no ␣ CD28, RA greatly enhanced the percentage of T cells expressing FoxP3 ( Fig. 3 D ) . In this experiment, co-stimulation still aff ected FoxP3 induction in a dosedependent manner, albeit to a substantially attenuated degree, as a result of the inclusion of RA. This suggests that RA lowers an as yet undefi ned threshold within the T cell, with this threshold determining whether the T cell can convert into a T reg cell. Thus, the presence of RA during antigen presentation allows TGF-␤ 1 -dependent FoxP3 induction to occur by T cells, even in the face of overt CD80/86 co-stimulation aff orded by the DC.
RA enhances FoxP3 expression without impeding T cell activation and proliferation
The observation that RA -T reg cells can be induced in the presence of high levels of co-stimulation led us the question whether this occurs by RA functioning to interrupt T cell activation and proliferation. To visualize this, CFSE-labeled CD4 ϩ CD25 Ϫ cells were stimulated in the presence and absence of 1 nM RA, with T cell activation determined by CD62L expression and proliferation by CFSE dye dilution. The data shows that 1 nM RA does not suppress T cell activation, as indicated by CD62L expression. Instead, RA appears to enhance T cell activation, as indicated by the decreased expression of CD62L across the three levels of activating conditions tested ( Fig. 4 A ) . Additionally, when CFSE histograms between diff erent culture conditions are overlaid, equivalent profi les indicate that the addition of RA does not impede T cell proliferation ( Fig. 4 B ) . The addition of TGF-␤ 1 to these cultures generated FoxP3 ϩ cells at expected frequencies throughout all peaks of cell division, with no impediment in cell division observed because of tolerance through RA -T reg cell induction. Finally, with the use of A-Tregs in cellular adoptive therapies on the horizon, the use of RA in vitro to facilitate the production of fully committed, gut-homing A-Tregs is an attractive technology to meet the needs for high numbers of these cells in the therapeutic treatment of autoimmune disorders such as infl ammatory bowel disease.
MATERIALS AND METHODS
Mice and immunizations. This study was approved by the Institutional Animal Care and Use Committee of Dartmouth College. C57BL/6 and C57BL/6 CD45.1 (Ly5.2 ϩ ) mice were purchased from the National Cancer Institute. C56BL/6 CD40 Ϫ / Ϫ mice were purchased from the Jackson Laboratory. FoxP3/GFP reporter mice were previously described and were provided by A. Rudensky (University of Washington School of Medicine, Seattle, WA) ( 20 ) . FoxP3/GFP mice were bred onto OTII TCR-Tg mice purchased from the Jackson Laboratory. CD80/86 double knockout mice on the C57BL/6 background were a gift from E. Usherwood (Dartmouth Medical School, Lebanon, NH). All animals were maintained in a pathogenfree facility at Dartmouth Medical School. For immunizations, OVA (Sigma-Aldrich) resuspended in PBS or PBS alone was emulsifi ed in CFA (Sigma-Aldrich) at a 1:1 ratio and intraperitoneally injected in a volume of 200 l.
Cell preparation. B cells and DCs were harvested from the spleens, and CD4 ϩ FoxP3 Ϫ cells were isolated from spleens and peripheral and mesenteric lymph nodes. For B cell and T cells, single-cell suspensions were generated by crushing organs by sterile slides and were purifi ed by positive selection using either ␣ CD4-or ␣ CD19-labeled magnetic beads (Miltenyi Biotec). T cells were further purifi ed by FACS sorting (FACSAria; BD Biosciences) of the CD4FoxP3/GFP Ϫ fraction, with purity always > 99.9%. For CD11c ϩ selection, spleens were harvested and incubated at 37 ° C in RPMI 1640 with 50 g/ml DNase I (Sigma-Aldrich) and 250 g/ml Liberase (Roche) for 30 min, pushed through a 100-M fi lter to create a single-cell suspension, and purifi ed using ␣ CD11c magnetic beads (Miltenyi Biotec). Cell preparations were always > 98% in purity. For small intestine lamina propria lymphocyte preparations, intestines were removed, and Peyer ' s Patches were excised and used for further analysis. The intestines were washed with cold PBS, split open, and cut into 1-cm pieces. After 30 min of incubation in unsupplemented RPMI to release the intestinal epithelial lymphocytes, intestines were vortexed, fi ltered using a 100-M fi lter, and extensively washed. Intestines were digested for 2 h using 50 g/ml DNase I and 250 g/ml Liberase, after which they were pushed through a 100-M fi lter. The cellular suspension was centrifuged and suspended in 40% Percoll, and overlaid on 60% Percoll. The Percoll gradient was spun at 400 g at room temperature for 25 min with no brake, with the buff y (lymphocyte) coat removed for further use. As indicated in the fi gures, APCs were pulsed with ISQ peptide at 10 g/ml for 1 h in cRPMI in sixwell plates at a concentration of 10 ϫ 10 6 cells/ml, and were washed, counted, and used.
Cell culture/reagents. Cells were cultured in RPMI 1640 media supplemented with 10% FBS (Atlanta Biologicals), Hepes, 50 M ␤ -ME, and penicillin/streptomycin/ l -glutamine. LPS was purchased from Sigma-Aldrich. ␣ CD40 (clone FGK-45), ␣ CD154 (clone MR1), ␣ CD28 (clone PV-1), and ␣ CD3 (clone 2C11) were purchased from ISC BioExpress. LE540 was purchased from Wako Chemicals. For 96-well plate cultures, 200,000 cells in APC/T cell co-cultures (1:1 ratio) in round-bottom plates or 100,000 T cells in fl at-bottom plates were cultured in 200 l of media. In each experiment, triplicate wells of each experimental condition were set up. For the bulk RA -T reg cell and A-Treg cultures in Fig. 2 and Fig. 5 , 24 -well fl at-well plates were used with 100,000 CD4 ϩ FoxP3 Ϫ cells/well in 1 ml of reg cells were more committed to the T reg cell lineage and less prone to revert to FoxP3 − T cells then A-Tregs in vivo. To examine the propensity of A-Tregs and RA -T reg cells to revert under diff erent in vivo conditions, these cells were generated from Ly5.2 ϩ OTII ϩ FoxP3/GFP reporter mice, sorted to > 99.9% FoxP3 ϩ , and transferred into Ly5.1 ϩ recipients. Hosts were either unmanipulated, or immunized with OVA/ CFA or PBS/CFA ( Fig. 5 A ) . After 5 d, the transferred cells were analyzed for FoxP3 expression. Very few (9%) RA -T reg cells lost FoxP3 expression in both the unmanipulated or CFA only mice, indicating stability in RA -T reg cell diff erentiation even in the presence of infl ammation. Surprisingly, a much larger percentage of A-Tregs lost FoxP3 expression in both unmanipulated and CFA only treated mice (40%) when compared with RA -T reg cells in similarly treated mice (9%). When injected with OVA/CFA, the frequency of FoxP3 ϩ cells was reduced in both RA -T reg cell and A-Treg populations at similar rates. As expected, these CD4 ϩ OTII ϩ cells expanded within the recipients upon antigen injection ( Fig. 5 B ) . In conclusion, RA -T reg cells were more refractory to reversion then A-Tregs under unmanipulated and infl ammatory conditions, yet antigen encounter with infl ammation drove partial reversion in both groups.
The data presented in this report shows that RA is a powerful inducer of FoxP3 expression and enhances commitment to the T reg cell lineage. The inclusion of RA during the generation of A-Tregs (a) imprints a gut-homing capacity, (b) allows FoxP3 induction in the presence of high levels of co-stimulation by attenuating the inhibitory impact of costimulation on FoxP3 induction, (c) increases the frequency and total numbers of FoxP3 ϩ T cells, and (d) induces T reg cells that are more refractory to reversion in vivo. Additionally, we implicate CD80/86 expression by APCs as a major mediator of A-Treg generation, as graded ligation of CD28 on the CD4 ϩ T cell surface has an inverse relationship with the capacity of that T cell to express FoxP3 in a TGF-␤ 1 -dependent manner. Collectively, these data underscore the potentially overwhelming impact of DCs producing RA within the gut on the fate of activated T cells. Despite their propensity to mediate A-Treg generation, it is unlikely that B cells contribute to dual gut imprinting and A-Treg generation. Unlike gut-derived DCs, B cells harvested from the spleen, Peyer ' s patches, or mesenteric lymph nodes do not imprint a gut-homing phenotype on CD4 ϩ T cells (unpublished data). Because of this, B cells are not likely to secrete RA in vivo.
The implications of these data are important. First, Powrie et al. and Agace et al. jointly described CD103 ϩ CD11c ϩ DCs present within the mesenteric lymph nodes, Peyer ' s Patches, and small and large bowel lamina propria as composing the DC subset responsible for mediating gut imprinting of T cells through CCR9 and ␣ 4 ␤ 7 induction. Second, these CD103 ϩ DCs likely imprint through an RA-dependent mechanism, although this has not yet been directly shown ( 9, 10 ) . Therefore, our data suggest a new role for RA in mediating not only gut imprinting but also in driving gut
